Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 960

1.

Endoscopic score vs blood cell indices for determining timing of immunomodulator withdrawal in quiescent ulcerative colitis.

Takenaka K, Tominaga K, Kanazawa M, Fukushi K, Tanaka T, Kanamori A, Sugaya T, Tsuchida K, Iijima M, Goda K, Irisawa A.

Sci Rep. 2019 Nov 28;9(1):17751. doi: 10.1038/s41598-019-54369-7.

2.

Colonic strictures mimicking Crohn's disease.

Takenaka K, Kimura M, Ohtsuka K.

Gut. 2019 Nov 28. pii: gutjnl-2019-320172. doi: 10.1136/gutjnl-2019-320172. [Epub ahead of print] No abstract available.

PMID:
31780573
3.

Publisher Correction: Decomposition and oxidation of methionine and tryptophan following irradiation with a nonequilibrium plasma jet and applications for killing cancer cells.

Uchida G, Mino Y, Suzuki T, Ikeda JI, Suzuki T, Takenaka K, Setsuhara Y.

Sci Rep. 2019 Nov 27;9(1):18140. doi: 10.1038/s41598-019-54737-3.

4.

Multiple esophageal ulcers due to tofacitinib 10 mg twice daily for ulcerative colitis.

Tominaga K, Kanazawa M, Takenaka K, Tanaka T, Sugaya T, Fukushi K, Takagi Y, Nagashima K, Abe K, Izawa N, Tsuchida K, Iijima M, Goda K, Yamagishi H, Irisawa A.

Clin J Gastroenterol. 2019 Nov 8. doi: 10.1007/s12328-019-01061-y. [Epub ahead of print]

PMID:
31705375
5.

Successful Cesarean Section Deliveries in a Patient with a History of Developmental Venous Anomaly-Induced Hemorrhage.

Nonaka Y, Yasuda S, Kumagai N, Kakino Y, Nakagawa J, Takenaka K.

J Stroke Cerebrovasc Dis. 2019 Dec;28(12):104461. doi: 10.1016/j.jstrokecerebrovasdis.2019.104461. Epub 2019 Oct 26.

PMID:
31662240
6.

The Iowa Gambling Task on HIV-infected subjects.

Nakao A, Yamanouchi J, Takenaka K, Takada K.

J Infect Chemother. 2019 Oct 10. pii: S1341-321X(19)30280-6. doi: 10.1016/j.jiac.2019.09.008. [Epub ahead of print]

PMID:
31607434
7.

[Allogeneic hematopoietic stem cell transplantation for myeloproliferative neoplasms].

Takenaka K.

Rinsho Ketsueki. 2019;60(9):1148-1156. doi: 10.11406/rinketsu.60.1148. Review. Japanese.

PMID:
31597838
8.

[Recognition of developmental disorders and the information sources among the Japanese adult population].

Arakida M, Fujita C, Takenaka K.

Nihon Koshu Eisei Zasshi. 2019;66(8):417-425. doi: 10.11236/jph.66.8_417. Japanese.

9.

Direct comparison of target-reactivity and cross-reactivity induced by CAR- and BiTE-redirected T cells for the development of antibody-based T-cell therapy.

Maruta M, Ochi T, Tanimoto K, Asai H, Saitou T, Fujiwara H, Imamura T, Takenaka K, Yasukawa M.

Sci Rep. 2019 Sep 16;9(1):13293. doi: 10.1038/s41598-019-49834-2.

10.

Small Bowel Healing Detected by Endoscopy in Patients With Crohn's Disease After Treatment With Antibodies Against Tumor Necrosis Factor.

Takenaka K, Fujii T, Suzuki K, Shimizu H, Motobayashi M, Hibiya S, Saito E, Nagahori M, Watanabe M, Ohtsuka K.

Clin Gastroenterol Hepatol. 2019 Aug 20. pii: S1542-3565(19)30899-7. doi: 10.1016/j.cgh.2019.08.024. [Epub ahead of print]

PMID:
31442600
11.

Chemical Interactions of Cryptic Actinomycete Metabolite 5-Alkyl-1,2,3,4-tetrahydroquinolines through Aggregate Formation.

Sugiyama R, Nakatani T, Nishimura S, Takenaka K, Ozaki T, Asamizu S, Onaka H, Kakeya H.

Angew Chem Int Ed Engl. 2019 Sep 16;58(38):13486-13491. doi: 10.1002/anie.201905970. Epub 2019 Aug 7. Review.

PMID:
31389661
12.

The clinical and economic burden of cytomegalovirus management post allogeneic hematopoietic stem cell transplantation in Japan - a retrospective database study.

Ueno R, Nishimura S, Fujimoto G, Piao Y, Takenaka K.

Curr Med Res Opin. 2019 Dec;35(12):2089-2096. doi: 10.1080/03007995.2019.1649379. Epub 2019 Aug 11.

PMID:
31353971
13.

[Clinical application of gene mutation information in myeloproliferative neoplasms].

Takenaka K.

Rinsho Ketsueki. 2019;60(6):610-618. doi: 10.11406/rinketsu.60.610. Review. Japanese.

PMID:
31281152
14.

Two cases of type 2 diabetes mellitus in elderly patients successfully treated with monthly exenatide long-acting release.

Takenaka K, Nishitani R.

Clin Case Rep. 2019 Apr 7;7(5):981-983. doi: 10.1002/ccr3.2139. eCollection 2019 May.

15.

Decrease in MPO-ANCA after administration of benralizumab in eosinophilic granulomatosis with polyangiitis.

Takenaka K, Minami T, Yoshihashi Y, Hirata S, Kimura Y, Kono H.

Allergol Int. 2019 Oct;68(4):539-540. doi: 10.1016/j.alit.2019.04.006. Epub 2019 May 9. No abstract available.

16.

Cholesterol Starvation and Hypoxia Activate the FVII Gene via the SREBP1-GILZ Pathway in Ovarian Cancer Cells to Produce Procoagulant Microvesicles.

Koizume S, Takahashi T, Yoshihara M, Nakamura Y, Ruf W, Takenaka K, Miyagi E, Miyagi Y.

Thromb Haemost. 2019 Jul;119(7):1058-1071. doi: 10.1055/s-0039-1687876. Epub 2019 May 5.

PMID:
31055798
17.

Long-term effect of NUDT15 R139C on hematologic indices in inflammatory bowel disease patients treated with thiopurine.

Akiyama S, Matsuoka K, Fukuda K, Hamada S, Shimizu M, Nanki K, Mizuno S, Kiyohara H, Arai M, Sugimoto S, Iwao Y, Ogata H, Hisamatsu T, Naganuma M, Motobayashi M, Suzuki K, Takenaka K, Fujii T, Saito E, Nagahori M, Ohtsuka K, Mochizuki M, Watanabe M, Hashiguchi M, Kanai T.

J Gastroenterol Hepatol. 2019 Oct;34(10):1751-1757. doi: 10.1111/jgh.14693. Epub 2019 Jun 26.

PMID:
31045285
18.

Decomposition and oxidation of methionine and tryptophan following irradiation with a nonequilibrium plasma jet and applications for killing cancer cells.

Uchida G, Mino Y, Suzuki T, Ikeda JI, Suzuki T, Takenaka K, Setsuhara Y.

Sci Rep. 2019 Apr 29;9(1):6625. doi: 10.1038/s41598-019-42959-4. Erratum in: Sci Rep. 2019 Nov 27;9(1):18140.

19.

Relationship between endoscopic mucosal healing and histologic inflammation during remission maintenance phase in ulcerative colitis: a retrospective study.

Kanazawa M, Takahashi F, Tominaga K, Abe K, Izawa N, Fukushi K, Nagashima K, Kanamori A, Takenaka K, Sugaya T, Iijima M, Takada A, Imai Y, Hiraishi H, Irisawa A.

Endosc Int Open. 2019 Apr;7(4):E568-E575. doi: 10.1055/a-0869-7619. Epub 2019 Apr 4.

20.

Adapalene Gel 0.1% Versus Placebo as Prophylaxis for Anti-Epidermal Growth Factor Receptor-Induced Acne-Like Rash: A Randomized Left-Right Comparative Evaluation (APPEARANCE).

Chayahara N, Mukohara T, Tachihara M, Fujishima Y, Fukunaga A, Washio K, Yamamoto M, Nakata K, Kobayashi K, Takenaka K, Toyoda M, Kiyota N, Tobimatsu K, Doi H, Mizuta N, Marugami N, Kawaguchi A, Nishigori C, Nishimura Y, Minami H.

Oncologist. 2019 Jul;24(7):885-e413. doi: 10.1634/theoncologist.2019-0156. Epub 2019 Mar 19.

21.

Escape hematopoiesis by HLA-B5401-lacking hematopoietic stem progenitor cells in men with acquired aplastic anemia.

Elbadry MI, Mizumaki H, Hosokawa K, Espinoza JL, Nakagawa N, Chonabayashi K, Yoshida Y, Katagiri T, Hosomichi K, Zaimoku Y, Imi T, Nguyen MAT, Fujii Y, Tajima A, Ogawa S, Takenaka K, Akashi K, Nakao S.

Haematologica. 2019 Oct;104(10):e447-e450. doi: 10.3324/haematol.2018.210856. Epub 2019 Mar 19. No abstract available.

22.

Comparison of Outcomes of Allogeneic Transplantation for Primary Myelofibrosis among Hematopoietic Stem Cell Source Groups.

Murata M, Takenaka K, Uchida N, Ozawa Y, Ohashi K, Kim SW, Ikegame K, Kanda Y, Kobayashi H, Ishikawa J, Ago H, Hirokawa M, Fukuda T, Atsuta Y, Kondo T.

Biol Blood Marrow Transplant. 2019 Aug;25(8):1536-1543. doi: 10.1016/j.bbmt.2019.02.019. Epub 2019 Mar 1.

PMID:
30826464
23.

Successful rescue transplantation with desensitization procedure after primary graft failure due to donor-specific antibody.

Minami M, Matsushima T, Mori Y, Ishihara D, Jinnnouchi F, Takenaka K, Henzan T, Yoshimoto G, Numata A, Kato K, Maeda T, Miyamoto T, Akashi K.

Bone Marrow Transplant. 2019 Aug;54(8):1374-1376. doi: 10.1038/s41409-019-0486-4. Epub 2019 Feb 25. No abstract available.

PMID:
30804490
24.

A Cross-sectional Survey of the Clinical Manifestations and Underlying Illness of Cough.

Otoshi T, Nagano T, Funada Y, Takenaka K, Nakata H, Ohnishi H, Nishiuma T, Nakajima T, Kageshita T, Tsuchiya T, Yamamoto M, Kobayashi K, Nishimura Y.

In Vivo. 2019 Mar-Apr;33(2):543-549. doi: 10.21873/invivo.11508.

25.

An Open-Label, Multi-Institutional, Randomized Study to Evaluate the Additive Effect of a Leukotriene Receptor Antagonist on Cough Score in Patients with Cough-Variant Asthma Being Treated with Inhaled Corticosteroids.

Miwa N, Nagano T, Ohnishi H, Nishiuma T, Takenaka K, Shirotani T, Nakajima T, Dokuni R, Kawa Y, Kobayashi K, Funada Y, Kotani Y, Nishimura Y.

Kobe J Med Sci. 2018 Dec 4;64(4):E134-E139.

26.

Giant isotropic negative thermal expansion in Y-doped samarium monosulfides by intra-atomic charge transfer.

Takenaka K, Asai D, Kaizu R, Mizuno Y, Yokoyama Y, Okamoto Y, Katayama N, Suzuki HS, Imanaka Y.

Sci Rep. 2019 Jan 15;9(1):122. doi: 10.1038/s41598-018-36568-w.

27.

Histone H3K27 Demethylase Negatively Controls the Memory Formation of Antigen-Stimulated CD8+ T Cells.

Yamada T, Nabe S, Toriyama K, Suzuki J, Inoue K, Imai Y, Shiraishi A, Takenaka K, Yasukawa M, Yamashita M.

J Immunol. 2019 Feb 15;202(4):1088-1098. doi: 10.4049/jimmunol.1801083. Epub 2019 Jan 9.

PMID:
30626691
28.

A decline in activities of daily living due to acute heart failure is an independent risk factor of hospitalization for heart failure and mortality.

Takabayashi K, Kitaguchi S, Iwatsu K, Morikami Y, Ichinohe T, Yamamoto T, Takenaka K, Takenaka H, Muranaka H, Fujita R, Nakajima O, Yokoyama R, Terasaki Y, Nishio H, Masai M, Koito H, Okuda M, Uwatoko H, Kawakami Y, Matsumoto S, Kitamura T, Nohara R.

J Cardiol. 2019 Jun;73(6):522-529. doi: 10.1016/j.jjcc.2018.12.014. Epub 2018 Dec 28.

PMID:
30598389
29.

A trafficking-deficient KCNQ1 mutation, T587M, causes a severe phenotype of long QT syndrome by interfering with intracellular hERG transport.

Wu J, Sakaguchi T, Takenaka K, Toyoda F, Tsuji K, Matsuura H, Horie M.

J Cardiol. 2019 May;73(5):343-350. doi: 10.1016/j.jjcc.2018.10.011. Epub 2018 Dec 24.

PMID:
30591322
30.

Hematemesis due to Drug Allergy to Oral Prednisolone in a Patient with Ulcerative Colitis.

Arisaka T, Kanazawa M, Tominaga K, Takahashi F, Takenaka K, Sugaya T, Arisaka O, Irisawa A, Hiraishi H.

Intern Med. 2019 Apr 15;58(8):1093-1096. doi: 10.2169/internalmedicine.1639-18. Epub 2018 Dec 18.

31.

Predictors of mucosal healing during induction therapy in patients with acute moderate-to-severe ulcerative colitis.

Motobayashi M, Matsuoka K, Takenaka K, Fujii T, Nagahori M, Ohtsuka K, Iwamoto F, Tsuchiya K, Negi M, Eishi Y, Watanabe M.

J Gastroenterol Hepatol. 2019 Jun;34(6):1004-1010. doi: 10.1111/jgh.14565. Epub 2019 Jan 4.

PMID:
30551266
32.

Safe childbirth for a type 1 antithrombin-deficient woman with novel mutation in the SERPINC1 gene undergoing antithrombin concentrate therapy.

Ikeda Y, Yamanouchi J, Hato T, Yasukawa M, Takenaka K.

Blood Coagul Fibrinolysis. 2019 Jan;30(1):47-51. doi: 10.1097/MBC.0000000000000785.

PMID:
30431449
33.

Crohn Disease: A 5-Point MR Enterocolonography Classification Using Enteroscopic Findings.

Kitazume Y, Fujioka T, Takenaka K, Oyama J, Ohtsuka K, Fujii T, Tateisi U.

AJR Am J Roentgenol. 2019 Jan;212(1):67-76. doi: 10.2214/AJR.17.18897. Epub 2018 Nov 13.

PMID:
30422709
34.

Enantioselective Aza-Wacker-Type Cyclization Promoted by Pd-SPRIX Catalyst.

Sen A, Takenaka K, Sasai H.

Org Lett. 2018 Nov 2;20(21):6827-6831. doi: 10.1021/acs.orglett.8b02946. Epub 2018 Oct 24.

PMID:
30354176
35.

Laterally Spreading Tumor-like Early Cancer in Ileum.

Yamasaki K, Takenaka K, Ohtsuka K.

Intern Med. 2019 Mar 15;58(6):885-886. doi: 10.2169/internalmedicine.1836-18. Epub 2018 Oct 17. No abstract available.

36.

Reinforce the antitumor activity of CD8+ T cells via glutamine restriction.

Nabe S, Yamada T, Suzuki J, Toriyama K, Yasuoka T, Kuwahara M, Shiraishi A, Takenaka K, Yasukawa M, Yamashita M.

Cancer Sci. 2018 Dec;109(12):3737-3750. doi: 10.1111/cas.13827. Epub 2018 Nov 2.

37.

Nimura lecture: why are you evaluating RV function in patients with pulmonary arterial hypertension?

Takenaka K.

J Echocardiogr. 2019 Mar;17(1):1-4. doi: 10.1007/s12574-018-0400-x. Epub 2018 Oct 5.

PMID:
30291508
38.

Plasma-enhanced reactive linear sputtering source for formation of silicon-based thin films.

Takenaka K, Setsuhara Y, Han JG, Uchida G, Ebe A.

Rev Sci Instrum. 2018 Aug;89(8):083902. doi: 10.1063/1.5037408.

PMID:
30184628
39.

Dedifferentiation process driven by TGF-beta signaling enhances stem cell properties in human colorectal cancer.

Nakano M, Kikushige Y, Miyawaki K, Kunisaki Y, Mizuno S, Takenaka K, Tamura S, Okumura Y, Ito M, Ariyama H, Kusaba H, Nakamura M, Maeda T, Baba E, Akashi K.

Oncogene. 2019 Feb;38(6):780-793. doi: 10.1038/s41388-018-0480-0. Epub 2018 Sep 4.

PMID:
30181548
40.

Human Herpes Virus-6-Associated Encephalitis/Myelitis Mimicking Calcineurin Inhibitor-Induced Pain Syndrome in Allogeneic Stem Cell Transplantation Recipients.

Yoshimoto G, Mori Y, Kato K, Shima T, Miyawaki K, Kikushige Y, Kamezaki K, Numata A, Maeda T, Takenaka K, Iwasaki H, Teshima T, Akashi K, Miyamoto T.

Biol Blood Marrow Transplant. 2018 Dec;24(12):2540-2548. doi: 10.1016/j.bbmt.2018.07.017. Epub 2018 Jul 17.

41.

Discovery of Presaccharothriolide X, a Retro-Michael Reaction Product of Saccharothriolide B, from the Rare Actinomycete Saccharothrix sp. A1506.

Lu S, Nishimura S, Takenaka K, Ito M, Kato T, Kakeya H.

Org Lett. 2018 Aug 3;20(15):4406-4410. doi: 10.1021/acs.orglett.8b01535. Epub 2018 Jul 19.

PMID:
30024763
42.

Progress of Research in Negative Thermal Expansion Materials: Paradigm Shift in the Control of Thermal Expansion.

Takenaka K.

Front Chem. 2018 Jul 2;6:267. doi: 10.3389/fchem.2018.00267. eCollection 2018. Review.

43.

Invasive Scopulariopsis alboflavescens infection in patient with acute myeloid leukemia.

Kurata K, Nishimura S, Ichikawa H, Sakai R, Mizutani Y, Takenaka K, Kakiuchi S, Miyata Y, Kitao A, Yakushijin K, Kawamoto S, Yamamoto K, Ito M, Matsuoka H, Tokimatsu I, Kamei K, Minami H.

Int J Hematol. 2018 Dec;108(6):658-664. doi: 10.1007/s12185-018-2496-1. Epub 2018 Jul 9.

PMID:
29987744
44.

Use of health promotion manga to encourage physical activity and healthy eating in Japanese patients with metabolic syndrome: a case study.

Shimazaki T, Matsushita M, Iio M, Takenaka K.

Arch Public Health. 2018 Jun 18;76:26. doi: 10.1186/s13690-018-0273-5. eCollection 2018.

45.

Gastrointestinal Graft-versus-Host Disease Is a Risk Factor for Postengraftment Bloodstream Infection in Allogeneic Hematopoietic Stem Cell Transplant Recipients.

Mori Y, Yoshimoto G, Nishida R, Sugio T, Miyawaki K, Shima T, Nagasaki Y, Miyake N, Harada Y, Kunisaki Y, Kamezaki K, Numata A, Kato K, Shiratsuchi M, Maeda T, Takenaka K, Iwasaki H, Shimono N, Akashi K, Miyamoto T.

Biol Blood Marrow Transplant. 2018 Nov;24(11):2302-2309. doi: 10.1016/j.bbmt.2018.06.002. Epub 2018 Jun 15.

46.

Prediction of disease activity of Crohn's disease through fecal calprotectin evaluated by balloon-assisted endoscopy.

Iwamoto F, Matsuoka K, Motobayashi M, Takenaka K, Kuno T, Tanaka K, Tsukui Y, Kobayashi S, Yoshida T, Fujii T, Saito E, Yamaguchi T, Nagahori M, Sato T, Ohtsuka K, Enomoto N, Watanabe M.

J Gastroenterol Hepatol. 2018 Dec;33(12):1984-1989. doi: 10.1111/jgh.14310. Epub 2018 Jun 27.

PMID:
29889986
47.

E‑cadherin regulates proliferation of colorectal cancer stem cells through NANOG.

Tamura S, Isobe T, Ariyama H, Nakano M, Kikushige Y, Takaishi S, Kusaba H, Takenaka K, Ueki T, Nakamura M, Akashi K, Baba E.

Oncol Rep. 2018 Aug;40(2):693-703. doi: 10.3892/or.2018.6464. Epub 2018 May 24.

48.

Previous exposure to bortezomib is linked to a lower risk of engraftment syndrome after autologous hematopoietic stem cell transplantation.

Mori Y, Yoshimoto G, Yuda JI, Hayashi M, Odawara J, Kuriyama T, Sugio T, Miyawaki K, Kamezaki K, Kato K, Takenaka K, Iwasaki H, Maeda T, Miyamoto T, Akashi K.

Leuk Lymphoma. 2019 Jan;60(1):271-273. doi: 10.1080/10428194.2018.1466295. Epub 2018 May 9. No abstract available.

PMID:
29741437
49.

Distribution of erlotinib in rash and normal skin in cancer patients receiving erlotinib visualized by matrix assisted laser desorption/ionization mass spectrometry imaging.

Nishimura M, Hayashi M, Mizutani Y, Takenaka K, Imamura Y, Chayahara N, Toyoda M, Kiyota N, Mukohara T, Aikawa H, Fujiwara Y, Hamada A, Minami H.

Oncotarget. 2018 Apr 6;9(26):18540-18547. doi: 10.18632/oncotarget.24928. eCollection 2018 Apr 6.

50.

The Validation of the Dai Nippon Medi·Ca SA Method for AOAC Research Institute Performance Tested MethodsSM Certification.

Shimizu M, Takenaka K, Suzuki T, Miyasaka A, Matsuda T, Iwase T, Kyotani H.

J AOAC Int. 2018 Sep 1;101(5):1522-1533. doi: 10.5740/jaoacint.17-0487. Epub 2018 Apr 19.

PMID:
29673418

Supplemental Content

Loading ...
Support Center